Extended-spectrum beta-lactamases in North America, 1987-2006.
about
ESBL-producing Enterobacteriaceae in Africa - a non-systematic literature review of research published 2008-2012Design, Synthesis, and Crystal Structures of 6-Alkylidene-2′-Substituted Penicillanic Acid Sulfones as Potent Inhibitors of Acinetobacter baumannii OXA-24 CarbapenemaseEmergence and Evolution of Multidrug-Resistant Klebsiella pneumoniae with both blaKPC and blaCTX-M Integrated in Chromosome.Development and validation of a resistance and virulence gene microarray targeting Escherichia coli and Salmonella enterica.Bench-to-bedside review: The role of beta-lactamases in antibiotic-resistant Gram-negative infections.First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United StatesForeign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model.A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infectionLaboratory detection of extended-spectrum-beta-lactamase-producing Enterobacteriaceae: evaluation of two screening agar plates and two confirmation techniquesPseudomonas aeruginosa: resistance to the maxESBLs: A Clear and Present Danger?Antibiotic-resistant Klebsiella pneumoniae and Escherichia coli high-risk clones and an IncFII(k) mosaic plasmid hosting Tn1 (blaTEM-4) in isolates from 1990 to 2004.Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat.Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United StatesCurrent epidemiology and growing resistance of gram-negative pathogens.Emergency surgery for tubo-ovarian abscess identified extended-spectrum beta-lactamase-producing Escherichia coli: the first case presentation revealing causative bacteriaAntimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014Comparison of SpectraCell RA typing and multilocus sequence typing for extended-spectrum-β-lactamase-producing Escherichia coli.Increasing Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States.Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131Emergence of extended-spectrum β-lactam resistance among Escherichia coli at a US academic children's hospital is clonal at the sequence type level for CTX-M-15, but not for CMY-2.Antibiotic susceptibility pattern and identification of extended spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae from Shiraz, Iran.Genetic mechanisms of antimicrobial resistance identified in Salmonella enterica, Escherichia coli, and Enteroccocus spp. isolated from U.S. food animalsSHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?β-Lactamase production in key gram-negative pathogen isolates from the Arabian PeninsulaCharacterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.Changes in the Frequencies of β-Lactamase Genes among Enterobacteriaceae Isolates in U.S. Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against β-Lactamase-Producing Isolates.Resistance profiles in surgical-site infection.Prolonged colonisation with Escherichia coli O25:ST131 versus other extended-spectrum beta-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014.Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns.Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacy.The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae.Incidence of Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: A Systematic Literature Review.Bloodstream infections in internal medicine.Antibacterial Activity of Some Plant Extracts Against Extended- Spectrum Beta-Lactamase Producing Escherichia coli IsolatesSpread of extended-spectrum beta-lactamase-producing Escherichia coli from a swine farm to the receiving river.CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from KoreaCarbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
P2860
Q26865931-BDCA5C37-5D67-43CD-9EA3-65BB95B9F740Q27664292-C0CC9944-0844-463E-BB41-F462284A82A4Q30401330-0B8E27AF-9BA3-45A9-B88B-F0A33EA71CB3Q33901083-10EA923B-2ED2-4B0C-B4DD-0522AEE142EDQ34026758-0978B4A7-8707-4798-8CF0-A8C43B2528C0Q34045397-0B7BE4A0-43AB-46DF-B8E1-775A3BE27468Q34108669-1C26585F-230D-404D-8408-332835A41D07Q34529381-931F03DA-34DE-472A-8FD0-826E59AEB7E6Q34582295-3960022F-96C5-47A1-9227-73C2135F5EE3Q34596627-58DC4067-F822-4DAE-B6F8-5FE294E9AC0EQ35084559-FEFC59CE-85B1-4599-8798-93EA8CEC14FCQ35101453-4864CA7A-2C23-481A-B6F4-C51F80488720Q35385731-FB5B655D-E3B1-4EED-A2B1-B6D0129099F7Q35555196-4FDDD5E7-29AD-4E44-BC41-DED7E0EF107CQ35867321-89C583B3-FA4B-47CA-9A7E-6ADD3347DAD6Q36025192-671ADB78-B3B1-47F0-8678-AD51F04036C0Q36028111-8D302F56-15D2-4B23-9CC9-960BD181EC61Q36298715-527B46A8-9DD2-45B3-BB17-D1B108B06C28Q36414108-BF2CF8C2-BCA4-4C3E-9039-21B7485AAFC6Q36566443-3C691B91-4B79-4EFF-B6A7-E4372FECBC25Q36727688-6D5685EE-028E-44A2-9956-23D59E8983E3Q36770280-497D19DD-2F27-497D-94C6-54CEEC20A7C6Q36804061-6A0CB963-DA32-45FB-89DB-A539E47669F7Q36868647-8481321D-5BE4-4C2D-B311-1A853A299AA8Q37007861-4A47E242-A1C9-4FC7-B476-9B5D709B0859Q37035803-E7568980-BDC8-48C7-B001-4AB6FB965530Q37092395-CDCBD9C2-0448-4D76-A0B7-B829B060FCDDQ37120191-8F8F2BD9-9D07-4C92-9047-60D7D189CC2AQ37225677-4A251AB6-3286-4091-A54C-1BAC7684AE3BQ37623615-E263BDF2-E5BA-4F0A-8772-8FBAC5E73B97Q37998436-DAB11CE7-49C3-45E7-92DB-79B8AACA113FQ38001333-4459D5C9-9B34-4F80-AF40-515033262EDBQ38314617-C75096C1-E83E-4256-9E3E-E34CB27B0A5DQ38497797-055D8904-207D-4664-B0FA-4711A719BFEAQ38652231-C565CC6F-3D88-4915-8B9E-CF745A8EE671Q38694666-F93DE99D-8EEF-4147-9B2A-F1ECEC381A67Q39027093-363820DB-E99A-4903-9019-0922BF6B2CF0Q41002269-902F1B6D-052E-4C68-9F39-D45634137362Q41036064-EE4BF058-7732-42DD-8485-A5CFA4814C99Q41217004-8726F450-0B35-4227-90EA-0E51465A3FFD
P2860
Extended-spectrum beta-lactamases in North America, 1987-2006.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Extended-spectrum beta-lactamases in North America, 1987-2006.
@en
Extended-spectrum beta-lactamases in North America, 1987-2006.
@nl
type
label
Extended-spectrum beta-lactamases in North America, 1987-2006.
@en
Extended-spectrum beta-lactamases in North America, 1987-2006.
@nl
prefLabel
Extended-spectrum beta-lactamases in North America, 1987-2006.
@en
Extended-spectrum beta-lactamases in North America, 1987-2006.
@nl
P1476
Extended-spectrum beta-lactamases in North America, 1987-2006.
@en
P2093
P304
P356
10.1111/J.1469-0691.2007.01848.X
P478
14 Suppl 1
P577
2008-01-01T00:00:00Z